Skip to main content
Clinical Trials/NCT01907204
NCT01907204
Completed
Phase 2

Evaluation of Inhaled Corticosteroid Treatment in Sinusitis

Cliniques universitaires Saint-Luc- Université Catholique de Louvain0 sites50 target enrollmentJuly 2013

Overview

Phase
Phase 2
Intervention
methylprednisolone
Conditions
Sinusitis
Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Enrollment
50
Primary Endpoint
Sniffin' Sticks Test
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The purpose of this study is to determine whether inhaled corticosteroid (specially nebulized) could be a good alternative to oral corticosteroid and whether they are effective in the treatment of sinusitis

Registry
clinicaltrials.gov
Start Date
July 2013
End Date
January 2014
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Responsible Party
Principal Investigator
Principal Investigator

G.Reychler

Docteur Gregory Reychler

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Eligibility Criteria

Inclusion Criteria

  • Nasal/Sinus polyps

Exclusion Criteria

  • Previous sinus surgery
  • Age under 18y
  • Use of antibiotics

Arms & Interventions

Oral

Oral drug (methylprednisolone) administration

Intervention: methylprednisolone

Metered dose inhaler

Intervention: Budesonide

Nebulized

Intervention: Budesonide

Outcomes

Primary Outcomes

Sniffin' Sticks Test

Time Frame: Baseline and day 15

Secondary Outcomes

  • Specific quality of life questionnaire (Snot 20)(Baseline and day 15)
  • Retro Olfaction Test(Baseline and day 15)

Similar Trials